Assignment: Assessing and Treating Pediatric Clients With

Assignment: Assessing and Treating Pediatric Clients With 

Assignment: Assessing and Treating Pediatric Clients With 

Assignment: Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N

 

The Assignment

Examine Case Study: An African American Child Suffering From Depression. You will

be asked to make three decisions concerning the medication to prescribe to this client.

Be sure to consider factors that might impact the client’s pharmacokinetic and

pharmacodynamic processes.

 At each decision point stop to complete the following:

o Decision #1

 Which decision did you select?

 Why did you select this decision? Support your response with evidence and references to the

Learning Resources.

 What were you hoping to achieve by making this decision? Support your response with

evidence and references to the Learning Resources.

 Explain any difference between what you expected to achieve with Decision #1 and the results

of the decision. Why were they different?

o Decision #2

 Why did you select this decision? Support your response with evidence and references to the

Learning Resources.

 What were you hoping to achieve by making this decision? Support your response with

evidence and references to the Learning Resources.

 Explain any difference between what you expected to achieve with Decision #2 and the results

of the decision. Why were they different?

o Decision #3

 Why did you select this decision? Support your response with evidence and references to the

Learning Resources.

 What were you hoping to achieve by making this decision? Support your response with

evidence and references to the Learning Resources.

 Explain any difference between what you expected to achieve with Decision #3 and the results

of the decision. Why were they different?

 Also include how ethical considerations might impact your treatment plan and communication

with clients.

Note: Support your rationale with a minimum of three academic resources. While you

may use the course text to support your rationale, it will not count toward the resource

requirement.

By Day 7

Submit your Assignment.

Submission and Grading Information

To submit your completed Assignment for review and grading, do the following:

 Please save your Assignment using the naming convention “WK2Assgn+last name+first

initial.(extension)” as the name.

 Click the Week 2 Assignment Rubric to review the Grading Criteria for the Assignment.

 Click the Week 2 Assignment link. You will also be able to “View Rubric” for grading criteria

from this area.

 Next, from the Attach File area, click on the Browse My Computer button. Find the document

you saved as “WK2Assgn+last name+first initial.(extension)” and click Open.

 If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my

paper(s) to the Global Reference Database.

 Click on the Submit button to complete your submission.

Grading Criteria

 

To access your rubric:

Week 2 Assignment Rubric

Check Your Assignment Draft for Authenticity

To check your Assignment draft for authenticity:

Submit your Week 2 Assignment draft and review the originality report.

Submit Your Assignment by Day 7

To submit your Assignment:

Week 2 Assignment

 

Making Connections

 

Now that you have:

 Assessed pediatric clients presenting with mood disorders

 Developed personalized plans of antidepressant therapy for pediatric clients

 Examined factors that influence pharmacokinetic and pharmacodynamic processes in pediatric

clients requiring antidepressant therapy

 Explored ethical and legal implications of prescribing antidepressant therapy to pediatric clients

Next week, you will build on your assessment and treatment skills as you examine adult

and geriatric clients presenting for antidepressant therapy.

Learning Resources

Note: To access this week’s required library resources, please click on the link to the

Course Readings List, found in the Course Materials section of your Syllabus.

Required Readings

Note: All Stahl resources can be accessed through this link provided.

Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and

practical applications (4th ed.). New York, NY: Cambridge University Press.

 

Note: To access the following chapters, click on the Essential Psychopharmacology,

4th ed tab on the Stahl Online website and select the appropriate chapter. Be sure to

read all sections on the left navigation bar for each chapter.

 Chapter 6, “Mood Disorders”

 Chapter 7, “Antidepressants”

Stahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge

University Press.

 

Note: To access the following medications, click on the The Prescriber's Guide, 5th

ed tab on the Stahl Online website and select the appropriate chapter. Be sure to read

all sections on the left navigation bar for each chapter.

 

Review the following medications:

 amitriptyline

 bupropion

 citalopram

 clomipramine

 desipramine

 desvenlafaxine

 doxepin

 duloxetine

 escitalopram

 fluoxetine

 fluvoxamine

 imipramine

 ketamine

 mirtazapine

 nortriptyline

 paroxetine

 selegiline

 sertraline

 trazodone

 venlafaxine

 vilazodone

 vortioxetine

 

Lorberg, B.,  Davico, C.,  Martsenkovskyi, D., & Vitiello, B. (2019).  Principles in using

psychotropic medication in children and adolescents. In J. M. Rey & A. Martin (Eds.),

IACAPAP e-Textbook of Child and Adolescent Mental Health. Geneva: International

Association for Child and Adolescent Psychiatry and Allied Professions. Retrieved from

https://iacapap.org/content/uploads/A.7-Psychopharmacology-2019.1.pdf

Magellan Health, Inc. (2013). Appropriate use of psychotropic drugs in children and

adolescents: A clinical monograph. Retrieved from

http://www.magellanhealth.com/media/445492/magellan-psychotropicdrugs-

0203141.pdf

Poznanski, E., & Mokros, H. (1996). Child Depression Rating Scale–Revised. Los

Angeles, CA: Western Psychological Services.

Note: Retrieved from Walden Library databases.

Rao, U. (2013). Biomarkers in pediatric depression. Depression & Anxiety, 30(9), 787-

791. doi:10.1002/da.22171

Required Media

Laureate Education (2016e). Case study: An African American child suffering from

depression [Interactive media file]. Baltimore, MD: Author.

 

Note: This case study will serve as the foundation for this week’s Assignment.

Optional Resources

El Marroun, H., White, T., Verhulst, F., & Tiemeier, H. (2014). Maternal use of

antidepressant or anxiolytic medication during pregnancy and childhood

neurodevelopmental outcomes: A systematic review. European Child & Adolescent

Psychiatry, 23(10), 973–992. doi:10.1007/s00787-014-0558-3

Gordon, M. S., & Melvin, G. A. (2014). Do antidepressants make children and

adolescents suicidal? Journal of Pediatrics and Child Health, 50(11), 847–854.

doi:10.1111/jpc.12655

Seedat, S. (2014). Controversies in the use of antidepressants in children and

adolescents: A decade since the storm and where do we stand now? Journal of Child &

Adolescent Mental Health, 26(2), iii–v. doi:10.2989/17280583.2014.938497

To prepare for this Assignment:

 Review this week’s Learning Resources. Consider how to assess and treat pediatric clients

requiring antidepressant therapy.

 

ORDER NOW FOR AN ORIGINAL PAPER ASSIGNMENT: Assignment: Assessing and Treating Pediatric Clients With Mood Disorders NURS 6630N

Get a 5 % discount on an order above $ 20
Use the following coupon code :
ESSAYHELP